TID-1S Antibodies

Santa Cruz Biotechnology offers a broad range of TID-1S monoclonal antibodies for investigating TID-1S in cellular processes. TID-1S Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TID-1S, or Tumor Invasion and Metastasis 1, plays essential roles in cellular signaling pathways that regulate cell growth, differentiation, and apoptosis. Research has shown TID-1S involvement in tumor progression and metastasis, making it a significant focus in cancer biology studies. Understanding TID-1S mechanisms and functions can reveal potential therapeutic targets for cancer treatment. Researchers worldwide utilize TID-1S monoclonal antibodies to advance their studies in both normal cellular processes and disease states. Ongoing investigations of TID-1S continue to uncover new insights into its biological significance and therapeutic potential. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific knowledge and potential therapeutic developments.